A 4-part illustration showing a radioligand molecule, a hand and clipboard with safety materials, a treatment chair, and a patient receiving radioligand therapy. An illustration of a US NRC form.

FAQs and resources

Radioactive materials (RAM) capabilities checklist

Refer to this checklist for key items and to download resources, such as sample documents, when preparing an RLT program to administer PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) and LUTATHERA® (lutetium Lu 177 dotatate).1,2

RAM license

Ensure the RAM license includes:

Hot lab

Ensure the hot lab:

Radioactive waste and disposal management

Ensure:

  • Treatment room

    Ensure the designated infusion room has:

    Bathroom

    Ensure the bathroom:

    Training and education

    Ensure the appropriate staff is trained and educated regarding:

    Standard operating procedures (SOPs)

    Ensure documentation exists for relevant SOPs, such as:

    Documents

    Ensure templates exist for:

    References: 1. Mittra ES, Wong RKS, Winters C, et al. Cancer Med. 2024;13(3):e6780. doi:10.1002/cam4.6780 2. Data on file. Expert Working Group Experience. Novartis Pharmaceuticals Corp; 2025.